Importance The overdose epidemic continues in the US, with 107 941 overdose deaths in
2022 and countless lives affected by the addiction crisis. Although widespread efforts to train …

Background: Research has shown that medications, especially opioid agonist treatments,
are an effective way to treat opioid use disorder (OUD); however, negative attitudes held by …

Importance As opioid-related deaths continue to climb, methods to reduce barriers to
prescribing buprenorphine for individuals with opioid use disorder (OUD) are needed …

Background This study examines racial/ethnic disparities in the use of medications for opioid
use disorder (MOUD) in residential treatment and the influence of race/ethnicity on the …

Objective To assess whether per capita buprenorphine distribution varies by regional
racial/ethnic composition, Medicaid expansion status, and time period. Methods Our unit of …

Importance Medication for opioid use disorder (MOUD)(eg, buprenorphine and naltrexone)
can be offered in primary care, but barriers to implementation exist. Objective To evaluate an …

Buprenorphine is a treatment medication that decreases mortality risks among people with
opioid use disorder (OUD). Despite its efficacy, buprenorphine is underused in the US …

Importance Buprenorphine treatment for opioid use disorder (OUD) is associated with
decreased morbidity and mortality. Despite its effectiveness, buprenorphine uptake has …

Research objective Medications for opioid use disorder (MOUDs)–including methadone,
buprenorphine, and naltrexone–are the most effective treatments for opioid use disorder …

Background: Increasing buprenorphine access is critical to facilitating effective opioid use
disorder treatment. Buprenorphine prescriber numbers have increased substantially, but …